(1986). Alford CA: Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA
(1991). Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.
(1999). Bertics PJ: Integrin-mediated migration of murine B82L fibroblasts is dependent on the expression of an intact epidermal growth factor receptor.
(2009). Cannon MJ: A social marketing approach to building a behavioural intervention for congenital cytomegalovirus. Health Promot Pract
(2007). Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol
(1990). Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS
(1980). Choppin PW: Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-terminal of the F1 or HA1 viral polypeptides. Virology
(2008). Cobbs C: Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection. Nature
(1990). Compans RW: Oligopeptide inhibitors of HIV-induced syncytium formation. AIDS Res Hum Retroviruses
(2002). Could an infectious trigger explain the differential maternal response to shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet Gynecol Scand
(2009). CR: Multiple peptides homologous to Herpes Simplex Virus Type 1 glycoprotein B inhibit viral infection. Antimicrob Agents and Chemotherapy
(2006). Crystal structure of the low- pH form of the vesicular stomatitis virus glycoprotein G. Science
(1998). Curtain CC: Efficacy of fusion peptide homologs in blocking cell lysis and HIV-induced fusion. AIDS Res Hum Retroviruses
(2009). De Clercq E, Snoeck R: Drug targets in cytomegalovirus infection. Infectious disorders-drug targets
(2002). Disulfide bond configuration of human cytomegalovirus glycoprotein B.
(1992). E: Are fusion peptides really “sided” insertional helices? Cell
(2006). Enfurvitide prevents vertical transmission of multidrugresistant HIV-1 in pregnancy but does not cross placenta. AIDS
(2003). FDA approves Fuzeon, the first fusion inhibitor.
(2003). Finberg RW: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol
(1986). GL: Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO
(1993). Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology
(1987). GS: The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. Anal Biochem
(2003). Huang ES: Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature
(2005). Huang ES: Integrin αvβ3 is a coreceptor for human cytomegalovirus. Nature Medicine
(1996). Human cytomegalovirus cell tropism and pathogenesis. Intervirology
(2009). Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread, but not for virion attachment, assembly, or egress.
(2000). Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.
(2004). Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis
(2008). I: The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat Struct Mol Biol
(2009). Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clin Microbiol Rev
(2004). JA: Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.
(1995). JA: Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis
(2000). Kawaoka Y: Functional importance of the coiled-coil of the Ebola virus glycoprotein.
(1996). KM: Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.
(1984). Kundsin RB: Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med
(1995). L: Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology
Mertens T: Antiviral intervention, resistance and perspectives. In Cytomegaloviruses Molecular biology and immunology. Edited by: Reddehase M.
(1996). Petteway SR Jr: Peptides from conserved regions of paramoxovirus fusion (F) proteins are potent inhibitors of viral fusion.
(2003). Radsak K: Differential effects of glycoprotein B epitope-specific antibodies on human cytomegalovirus-induced cell-cell fusion.
(1996). Radsak K: Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion.